The Cha Vaccine Institute, a vaccine development arm of Cha Medical and Bio Group, has developed its own messenger RNA delivery system which does not require frozen storage, the company said Friday. The firm expects that Lipoplex would be a more efficient and stable option than lipid nanoparticles, which have been widely used as carriers for mRNA vaccines. Medicines utilizing mRNA have gained traction since the COVID.
Cha Medical and Bio Group said Wednesday that the group will hold the Global Forum on Future Medicine 2023 at Cha Bio Complex in Seongnam, Gyeonggi Province, on Oct. 27. The forum will invite experts in stem cell research, regenerative medicine and cell and gene therapies, as well as officials from the government's regulatory agency. “The forum will provide opportunities for us to share the latest trends a.